Form 4 for CYTK CYTOKINETICS INC
Accepted 2024-05-16 00:00:00 ET · period of report 2024-05-15 · accession 0001127602-24-015721 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-05-16 | 2024-05-15 | CYTK | Kaye Edward M. MD | Dir | A - Grant | $0.00 | +5,600 | 24.9K | +29% | $0 |
| D | 2024-05-16 | 2024-05-15 | CYTK | Kaye Edward M. MD | Dir | A - Grant | $0.00 | +3,636 | 3,636 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-15 | A | A | 5,600 | $0.00 | 24,917 | D | — | — | |
| 2 | Derivative | Non-Qualified Stock Option (Right to Buy) | 2024-05-15 | A | A | 3,636 | $0.00 | 3,636 | D | $60.50 · 2024-06-17 to 2034-05-15 | 3,636 Common Stock |